CD56+ monocytes have been previously linked to inflammatory responses in rheumatoid arthritis (39) and as a prognostic marker in patients with coronavirus disease 2019 (COVID-19) (40, 41). The gene discussed is NCAM1; the disease is rheumatoid arthritis.